Sponsored message
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen
  • Listen Now Playing Listen
NPR News

Attorneys For Oklahoma Death Row Inmates Seek To Halt Executions

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today.

Listen 1:34

RENEE MONTAGNE, HOST:

And some may find details in this next brief story disturbing. Lawyers for 21 death row prisoners are in federal court today. Prisoners who were all incarcerated in Oklahoma. And they want an injunction to stop their executions after the state's botched lethal injection of Clayton Lockett this last spring, this after new revelations from the state's own investigation where the prison warden described that execution as a, quote, "bloody mess." NPR's Wade Goodwyn reports.

WADE GOODWYN, BYLINE: Lawyers for the condemned men argue Oklahoma is essentially conducting drug experiments on their clients, violating their Eighth Amendment rights. Death penalty states have been scrambling to find alternative execution drugs after European manufacturers refused to continue to sell to them. A key element of the federal court hearing will involve the use of the drug midazolam. Oklahoma used midazolam to replace pentobarbital for the first time on 38-year-old Clayton Lockett. Pentobarbital is an anesthetic, similar to what's used for surgery, but midazolam is not an anesthetic. It's a sedative, and that was likely a major factor why Lockett began to struggle and tried to get up from his gurney. According to the state's investigation, the participating physician hurriedly tried to put in a second line but hit an artery in Lockett's groin, spraying blood everywhere. The execution was finally halted, but Lockett died later anyway. Wade Goodwyn, NPR News, Dallas. Transcript provided by NPR, Copyright NPR.

You come to LAist because you want independent reporting and trustworthy local information. Our newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our connected community. We are free to tell the full truth, to hold power to account without fear or favor, and to follow facts wherever they lead. Our only loyalty is to our audiences and our mission: to inform, engage, and strengthen our community.

Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive from readers like you will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.

If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.

Your tax-deductible donation keeps LAist independent and accessible to everyone.
Senior Vice President News, Editor in Chief

Make your tax-deductible donation today